These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22327947)

  • 1. Frequency and nature of drug-drug interactions in a Swiss primary and secondary acute care hospital.
    Oertle M
    Swiss Med Wkly; 2012; 142():w13522. PubMed ID: 22327947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and nature of drug-drug interactions in a Dutch university hospital.
    Zwart-van Rijkom JE; Uijtendaal EV; ten Berg MJ; van Solinge WW; Egberts AC
    Br J Clin Pharmacol; 2009 Aug; 68(2):187-93. PubMed ID: 19694737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of high-risk drug-drug interactions in paediatric inpatients: a retrospective, single-centre cohort analysis.
    Dieu LW; Leuppi-Taegtmeyer AB; van den Anker J; Trachsel D; Gotta V
    Swiss Med Wkly; 2019 Aug; 149():w20103. PubMed ID: 31422575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug safety alert generation and overriding in a large Dutch university medical centre.
    van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reasons provided by prescribers when overriding drug-drug interaction alerts.
    Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
    Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Investigation of Drug-Drug Interaction Alert Overrides at a Pediatric Hospital.
    Humphrey K; Jorina M; Harper M; Dodson B; Kim SY; Ozonoff A
    Hosp Pediatr; 2018 May; 8(5):293-299. PubMed ID: 29700011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicians' responses to computerized drug-drug interaction alerts for outpatients.
    Yeh ML; Chang YJ; Wang PY; Li YC; Hsu CY
    Comput Methods Programs Biomed; 2013 Jul; 111(1):17-25. PubMed ID: 23608682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-drug interactions associated with length of stay and cost of hospitalization.
    Moura CS; Acurcio FA; Belo NO
    J Pharm Pharm Sci; 2009; 12(3):266-72. PubMed ID: 20067703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Physicians Causing Potential Drug-Drug Interactions in Ambulatory Care: A Pilot Study in Switzerland.
    Bucher HC; Achermann R; Stohler N; Meier CR
    PLoS One; 2016; 11(1):e0147606. PubMed ID: 26808430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of usage patterns and user perception of the drug-drug interaction database SFINX.
    Andersson ML; Böttiger Y; Bastholm-Rahmner P; Ovesjö ML; Vég A; Eiermann B
    Int J Med Inform; 2015 May; 84(5):327-33. PubMed ID: 25670228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patient safety in primary care: PREFASEG project].
    Catalán A; Borrell F; Pons A; Amado E; Baena JM; Morales V
    Med Clin (Barc); 2014 Jul; 143 Suppl 1():32-5. PubMed ID: 25128357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful strategy to improve the specificity of electronic statin-drug interaction alerts.
    Seidling HM; Storch CH; Bertsche T; Senger C; Kaltschmidt J; Walter-Sack I; Haefeli WE
    Eur J Clin Pharmacol; 2009 Nov; 65(11):1149-57. PubMed ID: 19641913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alerts for potassium-increasing drug-drug-interactions.
    Eschmann E; Beeler PE; Zünd G; Blaser J
    Stud Health Technol Inform; 2013; 192():1056. PubMed ID: 23920830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital.
    Cruciol-Souza JM; Thomson JC
    J Pharm Pharm Sci; 2006; 9(3):427-33. PubMed ID: 17207423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying high risk medications causing potential drug-drug interactions in outpatients: A prescription database study based on an online surveillance system.
    Toivo TM; Mikkola JA; Laine K; Airaksinen M
    Res Social Adm Pharm; 2016; 12(4):559-68. PubMed ID: 26459026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Patient-Specific Drug-Drug Interaction Alerting on the Frequency of Alerts: A Pilot Study.
    Horn J; Ueng S
    Ann Pharmacother; 2019 Nov; 53(11):1087-1092. PubMed ID: 31296026
    [No Abstract]   [Full Text] [Related]  

  • 18. Practitioners' views on computerized drug-drug interaction alerts in the VA system.
    Ko Y; Abarca J; Malone DC; Dare DC; Geraets D; Houranieh A; Jones WN; Nichol WP; Schepers GP; Wilhardt M
    J Am Med Inform Assoc; 2007; 14(1):56-64. PubMed ID: 17068346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative analysis of prescription activity and alert usage in a computerized physician order entry system.
    Wipfli R; Betrancourt M; Guardia A; Lovis C
    Stud Health Technol Inform; 2011; 169():940-4. PubMed ID: 21893884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.